Although the individual distributions of all the three ANGPTLs are different, these proteins, which are intricately regulated, appear to inhibit LPL activity and cause hypertriglyceridemia, the dynamics of which cannot be explained via a central dogma. The gene discussed is LPL; the disease is hypertriglyceridemia.